|
Molecular properties generated using the CDK |
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
N'-cyclopropyl-N-quinolin-6-yl-7H-purine-2,6-diamine |
Synonyms ![]() |
XC-302 | XC302 |
Comments |
Puquitinib is an orally active, PI3 kinase inhibitor that induces autophagy by inhibiting the PI3K/AKT/mTOR signaling pathway. Puquitinib is selective for p110δ relative to other PI3K class I enzymes. It is a clinical lead developed for antitumour activity [3]. Puquitinib is a 'pseudo' INN, that takes the form of an INN, but has not been submitted to the World Health Organisation for ratification. |
Database Links ![]() |
|
GtoPdb PubChem SID | 363894222 |
PubChem CID | 15983184 |
Search Google for chemical match using the InChIKey | QUTFBURLXCODBH-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | QUTFBURLXCODBH |
Search UniChem for chemical match using the InChIKey | QUTFBURLXCODBH-UHFFFAOYSA-N |
Search UniChem for chemicals with the same backbone | QUTFBURLXCODBH |